Rantuss Drugs Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 15-12-2024
- Paid Up Capital ₹ 0.10 M
as on 15-12-2024
- Company Age 12 Year, 6 Months
- Last Filing with ROC 31 Mar 2019
- Revenue %
(FY 2019)
- Ebitda
- Net Worth -11.11%
(FY 2019)
- Total Assets -10.00%
(FY 2019)
About Rantuss Drugs
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2019. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Ratna Kotti and Umamaheswara Kotte serve as directors at the Company.
- CIN/LLPIN
U24230TG2012PTC081440
- Company No.
081440
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
13 Jun 2012
- Date of AGM
30 Sep 2019
- Date of Balance Sheet
31 Mar 2019
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Rantuss Drugs?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ratna Kotti  | Director | 13-Jun-2012 | Current |
| Umamaheswara Kotte | Director | 13-Jun-2012 | Current |
Financial Performance of Rantuss Drugs.
Rantuss Drugs Private Limited, for the financial year ended 2019, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth observed a substantial decline by a decrease of 11.11%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss | |||||||
| Net Worth |
| ||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Rantuss Drugs?
In 2019, Rantuss Drugs had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Rantus Pharma Private LimitedActive 21 years 10 monthsRatna Kotti and Umamaheswara Kotte are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Rantuss Drugs?
Unlock and access historical data on people associated with Rantuss Drugs, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Rantuss Drugs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Rantuss Drugs's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
